Society for Endocrinology and the European Society of Endocrinology to launch new OA biomedical journal (Scope eknowledge center, 10 February 2012)
Analysis of updated ALSYMPCA phase III data confirms overall survival benefit of Alpharadin in castration-resistant prostate cancer patients with bone metastases (Reuters, 10 February 2012)

Obesity drug 'mediator' likely responsible for thousands of hospitalizations and deaths in France (Medical News Today, 10 February 2012)

13 Feb 2012

A new study shows that Benfluorex (Mediator®), which was used in France from 1976 to 2009 as an adjunct for the treatment of hyperlipidemia and in overweight patients with type 2 diabetes, was probably responsible for around 3,100 hospitalizations and 1,300 deaths due to valvular insufficiency.

Full article

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read